Escalon Medical Corp (ESMC) financial statements (2022 and earlier)

Company profile

Business Address 435 DEVON PARK ROAD
WAYNE, PA 19087
State of Incorp. PA
Fiscal Year End June 30
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,0661,2561,6511,6531,5311,366826
Cash and cash equivalents1,0661,2561,6511,6531,5311,366826
Restricted cash and investments256256256256256255255
Receivables1,3351,3581,0829731,1641,0461,313
Inventory, net of allowances, customer advances and progress billings1,4461,3881,4171,3741,3321,5851,785
Inventory1,4461,3881,4171,3741,3321,5851,785
Other current assets209196187151182179154
Total current assets:4,3114,4534,5934,4074,4644,4314,333
Noncurrent Assets
Operating lease, right-of-use asset7057758449119761,0421,107
Property, plant and equipment66738188949197
Intangible assets, net (including goodwill)9397102107112117122
Intangible assets, net (excluding goodwill)9397102107112117122
Deposits noncurrent assets63636363636363
Total noncurrent assets:9261,0081,0901,1701,2451,3121,389
TOTAL ASSETS:5,2385,4615,6835,5775,7095,7435,723
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,9402,0271,7981,7881,6351,8461,442
Accounts payable1,0491,1221,102955796920761
Accrued liabilities779793696721726814681
Interest and dividends payable112112 112112112 
Deferred revenue 276364494571468516
Debt249246708246246511426
Due to related parties  112   112
Disposal group, including discontinued operation  136 989490
Other liabilities131134 13541  
Other undisclosed current liabilities520227279691518273279
Total current liabilities:2,8412,9113,3973,3553,1093,1912,865
Noncurrent Liabilities
Long-term debt and lease obligation521581638702774848908
Long-term debt, excluding current maturities6789101112
Operating lease, liability515574630693765837897
Liabilities, other than long-term debt, including: 41414141459
Other liabilities 41414141  
Other undisclosed liabilities, other than long-term debt     459
Other undisclosed noncurrent liabilities(364)152147203371344429
Total noncurrent liabilities:6737748269461,1861,2371,346
Total liabilities:3,5143,6844,2234,3004,2954,4284,211
Stockholders' equity
Stockholders' equity attributable to parent1,7241,7771,4601,2761,4141,3151,512
Preferred stock645645645645645645645
Common stock7777777
Additional paid in capital69,70269,70269,70269,70269,70269,70269,702
Accumulated deficit(68,630)(68,577)(68,895)(69,078)(68,941)(69,039)(68,842)
Total stockholders' equity:1,7241,7771,4601,2761,4141,3151,512
TOTAL LIABILITIES AND EQUITY:5,2385,4615,6835,5775,7095,7435,723

Income statement (P&L) ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
Revenues2,7012,6752,8352,3252,8982,4142,015
Cost of revenue(1,540)(1,664)(1,491)(1,383)(1,666)(1,504)3,898
Cost of goods and services sold(1,540)(1,664)(1,491)(1,383)(1,666)(1,504) 
Gross profit:1,1611,0111,3439421,2329105,913
Operating expenses(1,210)(1,196)(1,157)(1,074)(1,129)(1,101) 
Other undisclosed operating loss      (6,377)
Operating income (loss):(49)(184)186(132)104(192)(465)
Nonoperating income (expense)(4)502(3)(5)(5)(5)(4)
Other nonoperating income 506     
Interest and debt expense(4)(5)(5)(5)(5)(6)(4)
Income (loss) from continuing operations before income taxes:(57)313178(143)93(202)(472)
Other undisclosed income from continuing operations  66   10
Net income (loss):(57)313244(143)93(202)(462)
Other undisclosed net income (loss) attributable to parent45(61)556(7)
Net income (loss) attributable to parent:(53)317184(137)98(197)(468)
Preferred stock dividends and other adjustments(13)(13)(13)(13)(13)(13)(13)
Net income (loss) available to common stockholders, basic:(66)304171(150)85(210)(481)
Convertible preferred dividends 13  13  
Other undisclosed net income available to common stockholders, diluted      13
Net income (loss) available to common stockholders, diluted:(66)317171(150)98(210)(468)

Comprehensive Income ($ in thousands)

12/31/2021
Q2
9/30/2021
Q1
6/30/2021
Q4
3/31/2021
Q3
12/31/2020
Q2
9/30/2020
Q1
6/30/2020
Q4
Net income (loss):(57)313244(143)93(202)(462)
Comprehensive income (loss), net of tax, attributable to parent:(57)313244(143)93(202)(462)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: